Evidence map›Paper›PMID 35261053›Full record

ArticleStatistics in medicine2022

Bayesian models for aggregate and individual patient data component network meta-analysis.

Orestis Efthimiou, Michael Seo, Eirini Karyotaki, Pim Cuijpers, Toshi A Furukawa, Guido Schwarzer, Gerta Rücker, Dimitris Mavridis

Open access · hybridAbstract readNetwork Meta-Analysis
In one paragraph

Article in Statistics in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 2 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 2 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 6 institutions in 8 countries.

Orestis EfthimiouInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID 0000-0002-0955-7572
Michael SeoInstitute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.ORCID 0000-0002-5229-590X
Eirini KaryotakiDepartment of Global Health and Social Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Pim CuijpersDepartment of Clinical Neuro- and Developmental Psychology, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Toshi A FurukawaDepartments of Health Promotion and Human Behavior and of Clinical Epidemiology, Kyoto University Graduate School of Medicine/School of Public Health, Kyoto, Japan.
Guido SchwarzerInstitute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
Gerta RückerInstitute of Medical Biometry and Statistics, Faculty of Medicine and Medical Center, University of Freiburg, Freiburg, Germany.
Dimitris MavridisDepartment of Primary Education, University of Ioannina, Ioannina, Greece.ORCID 0000-0003-1041-4592
University of Bern · CHUniversity of Freiburg · DEDélégation Paris 5 · FRHarvard University · USKyoto University · JPVrije Universiteit Amsterdam · NL

Funding

Swiss National Science Foundation 180083
6 · The paper itself

Abstract

Network meta-analysis can synthesize evidence from studies comparing multiple treatments for the same disease. Sometimes the treatments of a network are complex interventions, comprising several independent components in different combinations. A component network meta-analysis (CNMA) can be used to analyze such data and can in principle disentangle the individual effect of each component. However, components may interact with each other, either synergistically or antagonistically. Deciding which interactions, if any, to include in a CNMA model may be difficult, especially for large networks with many components. In this article, we present two Bayesian CNMA models that can be used to identify prominent interactions between components. Our models utilize Bayesian variable selection methods, namely the stochastic search variable selection and the Bayesian LASSO, and can benefit from the inclusion of prior information about important interactions. Moreover, we extend these models to combine data from studies providing aggregate information and studies providing individual patient data (IPD). We illustrate our models in practice using three real datasets, from studies in panic disorder, depression, and multiple myeloma. Finally, we describe methods for developing web-applications that can utilize results from an IPD-CNMA, to allow for personalized estimates of relative treatment effects given a patient's characteristics.

Indexed as

Research DesignBayes TheoremHumanscomplex interventionscompositemodel selectionmultiple treatments

Identifiers

PMID35261053
PMCPMC9314605
OpenAlexW4221008954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.